Theratechnologies Welcomes Jordan Zwick to its Board of Directors

Jordan Zwick joins Theratechnologies' board, bringing extensive biotech and pharmaceutical industry experience.

Jordan Zwick appointed to Theratechnologies' Board of Directors and Audit Committee.
Zwick brings a wealth of experience from his roles at Mirador Therapeutics and other biopharmaceutical companies.
Appointment aims to guide Theratechnologies towards near-term profitability through product sales and asset acquisition.
Zwick's previous successes include strategic advisory roles and a key role in the sale of Salix Pharmaceuticals.
Theratechnologies focuses on developing innovative therapies to address unmet medical needs.